Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials.

Source:http://linkedlifedata.com/resource/pubmed/id/1705571

J. Immunol. Methods 1991 Feb 15 136 2 221-37

Download in:

View as

General Info

PMID
1705571